• Home
  • About
  • ‘Enforcement 40’ for 2020
  • Webcasts
  • Enforcement Hall of Fame
  • Contact
Securities Docket
FTI 480x60
  • Class Actions
  • Criminal
  • Global
  • People
  • SD Insider
  • SEC
  • Video
  • Subscribe by email
  • Subscribe
Browse: Home / 2010 / January / 11 / SEC Files Settled Insider Trading Case Against Former Indevus Exec

SEC Files Settled Insider Trading Case Against Former Indevus Exec

By Securities Docket on January 11, 2010, 3:22 pm

The SEC today filed a settled injunctive action alleging insider trading against Brooke D. Wagner, former vice president of corporate communications at Indevus Pharmaceuticals. The SEC alleges that Wagner sold shares of Indevus stock upon learning in advance that the U.S. Food and Drug Administration (FDA) had expressed concerns about a potential side effect of a drug for which Indevus was seeking FDA approval, and, as a result, the approval process would be delayed by at least 18 months.  According to the SEC’s complaint, when that information was disclosed, the closing price of Indevus stock fell $2.84 per share from the prior day’s closing price of $4.10 per share to $1.26 per share, a decline of 69%.

The SEC stated that Wagner has agreed to disgorge ill-gotten gains of $64,190.46, pay prejudgment interest of $4,741.57, and pay a civil monetary payment of $64,190.46.

Blog Widget by LinkWithin

Posted in SEC | Tagged Insider Trading, Settlements

« Previous Next »

Subscribe

‘Enforcement 40’ for 2020

Ankura 260x250

Our Sponsors

Securities-Docket_260x125_14Sec Ankura 260x125

Join Us On LinkedIn

Join the Securities Litigation and Enforcement Group on LinkedIn

Archives

Copyright © 2022 Securities Docket.

Powered by WordPress and Hybrid.